PHASE-II STUDY WITH THE COMBINATION ETOPOSIDE, DOXORUBICIN, AND CISPLATIN IN ADVANCED MEASURABLE GASTRIC-CANCER

被引：296
作者：
PREUSSER, P
WILKE, H
ACHTERRATH, W
FINK, U
LENAZ, L
HEINICKE, A
MEYER, J
MEYER, HJ
BUENTE, H
机构：
[1] UNIV CLIN MUENSTER, DEPT SURG, MED ONCOL SECT, MUNSTER, FED REP GER
[2] UNIV HANOVER, SCH MED, DEPT HEMATOL ONCOL, D-3000 HANOVER, FED REP GER
[3] UNIV HANOVER, SCH MED, DEPT SURG, D-3000 HANOVER, FED REP GER
[4] BRISTOL MYERS CO, ANTICANC RES, NEW YORK, NY USA
[5] TECH UNIV MUNICH, MED CLIN, D-8000 MUNICH 2, FED REP GER
[6] UNIV MUNSTER, INST MED INFORMAT & BIOMATH, D-4400 MUNSTER, FED REP GER
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1989年 / 7卷 / 09期
关键词：
D O I：
10.1200/JCO.1989.7.9.1310
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1310 / 1317
页数：8
相关论文
共 72 条
[1]   ETOPOSIDE - CHEMISTRY, PRE-CLINICAL AND CLINICAL-PHARMACOLOGY [J].
ACHTERRATH, W ;
NIEDERLE, N ;
RAETTIG, R ;
HILGARD, P .
CANCER TREATMENT REVIEWS, 1982, 9 :3-13
[2]  
BEHARS OH, 1983, MANUAL STAGING CANCE, P67
[3]  
BERETTA G, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P94
[4]  
BERETTA G, 1982, P AN M AM SOC CLIN, V23, P103
[5]  
BERETTA G, 1983, P AN M AM SOC CLIN, V2, P131
[6]  
BERNATH AM, 1979, P AM ASSOC CANC RES, V20, P312
[7]  
BIRAN H, 1984, P AN M AM SOC CLIN, V3, P132
[8]  
BORCHARD F, 1985, THERAPIEWOCHE, V35, P161
[9]  
CARTEI G, 1985, MITOMYCIN 85 AKTUELL, P56
[10]  
CAZAP EL, 1986, CANCER TREAT REP, V70, P781
12345678